Discover Tenders by Drugs Cancer Oncology Sector

Find the most relevant tenders for Drugs Cancer Oncology. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Drugs Cancer Oncology tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Drugs Cancer Oncology tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Lipegfilgrastim Atc Code According To Who L03Aa14

Deadline: 30 Apr 2026

Germany

Ref. No.: 6174040

EMD:Ref Document

Bid Value: Ref Document

186 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For Drugs With The Trade Name Orylmyte Atc Code According To Who V01Aa03

Deadline: 31 Jul 2026

Germany

Ref. No.: 6173952

EMD:Ref Document

Bid Value: Ref Document

278 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For Drugs With The Trade Name Itulazax Atc Code According To Who V01Aa05

Deadline: 31 Jul 2026

Germany

Ref. No.: 6171828

EMD:Ref Document

Bid Value: Ref Document

278 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open House Model For The Active Ingredient Fentanyl In The Dosage Form Of Sublingual Tablets Atc Code According To Wh

Deadline: 30 Jun 2026

Germany

Ref. No.: 6165516

EMD:Ref Document

Bid Value: Ref Document

247 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Ustekinumab

Deadline: 10 Aug 2026

Germany

Ref. No.: 6108284

EMD:Ref Document

Bid Value: Ref Document

288 Days Left

Open Framework Agreement On Drug Discounts In Accordance With Section 130A Paragraph 8 Of The Social Code Book V With The Option To Join At Any Time So Called Approval Model 2024 06

Deadline: 05 Jun 2026

Germany

Ref. No.: 6107624

EMD:Ref Document

Bid Value: Ref Document

222 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Lisdexamfetamine

Deadline: 10 Nov 2025

Germany

Ref. No.: 6072974

EMD:Ref Document

Bid Value: Ref Document

15 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Ustekinumab

Deadline: 10 Aug 2026

Germany

Ref. No.: 6065652

EMD:Ref Document

Bid Value: Ref Document

288 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Lisdexamfetamine

Deadline: 10 Nov 2025

Germany

Ref. No.: 6040123

EMD:Ref Document

Bid Value: Ref Document

15 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Epinephrine In The Dosage Form Ilo

Deadline: 10 May 2026

Germany

Ref. No.: 5978859

EMD:Ref Document

Bid Value: Ref Document

196 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Filgrastim Atc Code According To Who L03Aa02

Deadline: 30 Jun 2026

Germany

Ref. No.: 5978377

EMD:Ref Document

Bid Value: Ref Document

247 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Ebastine In The Strength 20 Mg And The Dosage Form Smt

Deadline: 10 May 2026

Germany

Ref. No.: 5978310

EMD:Ref Document

Bid Value: Ref Document

196 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Somatropin Atc Code According To Who H01Ac01

Deadline: 31 Jul 2026

Germany

Ref. No.: 5977915

EMD:Ref Document

Bid Value: Ref Document

278 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Brimonidine In The Dosage Form Edp

Deadline: 10 May 2026

Germany

Ref. No.: 5977462

EMD:Ref Document

Bid Value: Ref Document

196 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Baclofen In The Dosage Form Inf

Deadline: 10 May 2026

Germany

Ref. No.: 5976401

EMD:Ref Document

Bid Value: Ref Document

196 Days Left

Showing 45736 to 45750 of 45912 results

‹
1
2
...
3047
3048
3049
3050
3051
3052
3053
...
3060
3061
›

Discover Tenders by Drugs Cancer Oncology Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Drugs Cancer Oncology Sector

Filter Your Search

FREE Trial plan for all new users!